loadpatents
name:-0.10213685035706
name:-0.080857992172241
name:-0.009415864944458
Flynn; Daniel L. Patent Filings

Flynn; Daniel L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Flynn; Daniel L..The latest application filed is for "gcn2 and perk kinase inhibitors and methods of use thereof".

Company Profile
10.79.93
  • Flynn; Daniel L. - Waltham MA
  • Flynn; Daniel L. - Lawrence KS
  • - Lawrence KS US
  • Flynn; Daniel L. - Natick MA
  • Flynn; Daniel L - Mundelein IL
  • Flynn, Daniel L. - Mundelein IL
  • Flynn, Daniel L. - Clarkson Valley MO
  • Flynn; Daniel L. - Ann Arbor MI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Gcn2 And Perk Kinase Inhibitors And Methods Of Use Thereof
App 20220274934 - Flynn; Daniel L. ;   et al.
2022-09-01
Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
Grant 11,390,611 - Flynn , et al. July 19, 2
2022-07-19
Anti-viral Activity Of Vps34 Inhibitors
App 20220193083 - Flynn; Daniel L.
2022-06-23
Anti-viral Activity Of Vps34 Inhibitors
App 20220184077 - Flynn; Daniel L.
2022-06-16
Anti-viral Activity Of Vps34 Inhibitors
App 20220184050 - Flynn; Daniel L.
2022-06-16
Anti-viral Activity Of Vps34 Inhibitors
App 20220184092 - Flynn; Daniel L.
2022-06-16
Anti-viral Activity Of Vps34 Inhibitors
App 20220184093 - Flynn; Daniel L.
2022-06-16
Anti-viral Activity Of Vps34 Inhibitors
App 20220184054 - Flynn; Daniel L.
2022-06-16
Methods Of Treating Disorders Using Csf1r Inhibitors
App 20220143018 - Flynn; Daniel L. ;   et al.
2022-05-12
Methods For Treating Vascular Malformations
App 20220047573 - Flynn; Daniel L. ;   et al.
2022-02-17
Use Of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthy- Ridin-3-yl]-2-fluorophenyl]-3-phenylurea And Analogs For The Treatment Of Cancers Associated With Genetic Abnormalities In Platelet Derived Growth Factor Receptor Alpha
App 20220031678 - Flynn; Daniel L. ;   et al.
2022-02-03
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
Grant RE48,731 - Flynn , et al. September 14, 2
2021-09-14
Methods of treating disorders using CSF1R inhibitors
Grant 11,103,507 - Flynn , et al. August 31, 2
2021-08-31
Combination Therapy For The Treatment Of Gastrointestinal Stromal Tumor
App 20210145805 - Flynn; Daniel L. ;   et al.
2021-05-20
Aminopyrimidine Amide Autophagy Inhibitors And Methods Of Use Thereof
App 20210128556 - Flynn; Daniel L. ;   et al.
2021-05-06
Use Of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthy- Ridin-3-yl]-2-fluorophenyl]-3-phenylurea And Analogs For The Treatment Of Cancers Associated With Genetic Abnormalities In Platelet Derived Growth Factor Receptor Alpha
App 20210015801 - Flynn; Daniel L. ;   et al.
2021-01-21
Heteroarylaminopyrimidine Amide Autophagy Inhibitors And Methods Of Use Thereof
App 20200354346 - Flynn; Daniel L. ;   et al.
2020-11-12
Phenylaminopyrimidine Amide Autophagy Inhibitors And Methods Of Use Thereof
App 20200354352 - Flynn; Daniel L. ;   et al.
2020-11-12
Combination Therapy For The Treatment Of Mastocytosis
App 20200352920 - Flynn; Daniel L. ;   et al.
2020-11-12
Methods Of Treating Disorders Using Csf1r Inhibitors
App 20200253973 - Kind Code
2020-08-13
Use Of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthy- Ridin-3-yl]-2-fluorophenyl]-3-phenylurea And Analogs
App 20200129489 - Flynn; Daniel L. ;   et al.
2020-04-30
Methods For Inhibiting Tie-2 Kinase Useful In The Treatment Of Cancer
App 20190091217 - FLYNN; Daniel L. ;   et al.
2019-03-28
Methods For Inhibiting Tie-2 Kinase Useful In The Treatment Of Cancer
App 20170209428 - Flynn; Daniel L. ;   et al.
2017-07-27
Inhibition Of Tumor Cell Interactions With The Microenvironment Resulting In A Reduction In Tumor Growth And Disease Progression
App 20170079966 - FLYNN; Daniel L. ;   et al.
2017-03-23
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
Grant 9,457,019 - Flynn , et al. October 4, 2
2016-10-04
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,387,202 - Flynn , et al. July 12, 2
2016-07-12
N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,382,228 - Flynn , et al. July 5, 2
2016-07-05
RAF inhibitor compounds
Grant 9,334,267 - Flynn , et al. May 10, 2
2016-05-10
Inhibition Of Trk Kinase Mediated Tumor Growth And Disease Progression
App 20160101090 - FLYNN; Daniel L. ;   et al.
2016-04-14
N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,309,224 - Flynn , et al. April 12, 2
2016-04-12
Imidazolidinones And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20160046619 - Flynn; Daniel L. ;   et al.
2016-02-18
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,193,719 - Flynn , et al. November 24, 2
2015-11-24
Raf inhibitor compounds
Grant 9,187,474 - Flynn , et al. November 17, 2
2015-11-17
Dihydronaphthyridines And Related Compounds Useful As Kinase Inhibitors For The Treatment Of Proliferative Diseases
App 20150320759 - Flynn; Daniel L. ;   et al.
2015-11-12
2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,181,223 - Kaufman , et al. November 10, 2
2015-11-10
Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,133,183 - Flynn , et al. September 15, 2
2015-09-15
Methods For Inhibiting Tie-2 Kinase Useful In The Treatment Of Cancer
App 20150246033 - Flynn; Daniel L. ;   et al.
2015-09-03
Cyclopropyl Dicarboxamides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20150218130 - Flynn; Daniel L. ;   et al.
2015-08-06
Pyridone Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20150148380 - FLYNN; Daniel L. ;   et al.
2015-05-28
Raf Inhibitor Compounds
App 20150119392 - Flynn; Daniel L. ;   et al.
2015-04-30
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,012,635 - Flynn , et al. April 21, 2
2015-04-21
Raf Inhibitor Compounds
App 20150105367 - Flynn; Daniel L. ;   et al.
2015-04-16
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
Grant 8,940,756 - Flynn , et al. January 27, 2
2015-01-27
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 8,921,565 - Flynn , et al. December 30, 2
2014-12-30
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 08921565 -
2014-12-30
Pyridone Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20140343103 - Flynn; Daniel L. ;   et al.
2014-11-20
Imidazolidinones And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20140315917 - Flynn; Daniel L. ;   et al.
2014-10-23
1,2,4-triazol-5-ones And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20140296252 - Flynn; Daniel L. ;   et al.
2014-10-02
2-aminopyrimidin-6-ones And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20140275085 - Kaufman; Michael D. ;   et al.
2014-09-18
N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
App 20140275016 - Flynn; Daniel L. ;   et al.
2014-09-18
N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
App 20140275080 - Flynn; Daniel L. ;   et al.
2014-09-18
Cyclopropyl Dicarboxamides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20140194405 - Flynn; Daniel L. ;   et al.
2014-07-10
Raf inhibitor compounds
Grant 8,741,911 - Allgeier , et al. June 3, 2
2014-06-03
Dihydronaphthyridines And Related Compounds Useful As Kinase Inhibitors For The Treatment Of Proliferative Diseases
App 20140088075 - Flynn; Daniel L. ;   et al.
2014-03-27
Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 8,637,672 - Flynn , et al. January 28, 2
2014-01-28
Pyridone Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20130317066 - Flynn; Daniel L. ;   et al.
2013-11-28
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
Grant 8,586,565 - Flynn , et al. November 19, 2
2013-11-19
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 8,569,319 - Flynn , et al. October 29, 2
2013-10-29
Raf Inhibitor Compounds
App 20130252977 - Allgeier; Matthew Carl ;   et al.
2013-09-26
Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 8,486,951 - Flynn , et al. July 16, 2
2013-07-16
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
Grant 8,461,179 - Flynn , et al. June 11, 2
2013-06-11
Cyclopropane Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20130079362 - Flynn; Daniel L. ;   et al.
2013-03-28
Cyclopropyl Dicarboxamides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20120322834 - Flynn; Daniel L. ;   et al.
2012-12-20
Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases
App 20120289540 - Flynn; Daniel L. ;   et al.
2012-11-15
Cyclopropyl Dicarboxamides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20120252849 - Flynn; Daniel L. ;   et al.
2012-10-04
N-acyl ureas exhibiting anti-cancer and anti-proliferative activities
Grant 8,278,331 - Flynn , et al. October 2, 2
2012-10-02
Methods And Compositions For The Treatment Of Myeloproliferative Diseases And Other Proliferative Diseases
App 20120225057 - Flynn; Daniel L. ;   et al.
2012-09-06
Pyridone Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20120172382 - Flynn; Daniel L. ;   et al.
2012-07-05
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
Grant 8,188,113 - Flynn , et al. May 29, 2
2012-05-29
Enzyme modulators and treatments
Grant 8,163,756 - Flynn , et al. April 24, 2
2012-04-24
Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
Grant 8,143,293 - Flynn , et al. March 27, 2
2012-03-27
Cyclopropyl Dicarboxamides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20120058985 - FLYNN; DANIEL L. ;   et al.
2012-03-08
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
App 20110189167 - FLYNN; Daniel L. ;   et al.
2011-08-04
Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and other Proliferative Diseases
App 20110136760 - Flynn; Daniel L. ;   et al.
2011-06-09
Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases
App 20110118271 - FLYNN; Daniel L. ;   et al.
2011-05-19
Kinase inhibitors useful for the treatment of proliferative diseases
Grant 7,897,762 - Flynn , et al. March 1, 2
2011-03-01
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
Grant 7,790,756 - Flynn , et al. September 7, 2
2010-09-07
Anti-inflammatory medicaments
Grant 7,737,283 - Flynn , et al. June 15, 2
2010-06-15
Cyclopropane Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20100120806 - Flynn; Daniel L. ;   et al.
2010-05-13
Anti-inflammatory medicaments
Grant 7,666,895 - Flynn , et al. February 23, 2
2010-02-23
Anti-inflammatory Medicaments
App 20090312349 - Flynn; Daniel L. ;   et al.
2009-12-17
Anti-inflammatory medicaments
App 20090137021 - Flynn; Daniel L. ;   et al.
2009-05-28
Anti-inflammatory medicaments
Grant 7,531,566 - Flynn , et al. May 12, 2
2009-05-12
Anti-inflammatory medicaments
App 20090105230 - Flynn; Daniel L. ;   et al.
2009-04-23
Kinase inhibitors useful for the treatment of proliferative diseases
App 20090099190 - Flynn; Daniel L. ;   et al.
2009-04-16
Anti-inflammatory medicaments
App 20090075986 - Flynn; Daniel L. ;   et al.
2009-03-19
Anti-inflammatory medicaments
App 20090069310 - Flynn; Daniel L. ;   et al.
2009-03-12
Anti-inflammatory medicaments
App 20080299639 - Flynn; Daniel L. ;   et al.
2008-12-04
Kinase Inhibitors Useful For The Treatment Of Myleoprolific Diseases And Other Proliferative Diseases
App 20080269254 - Flynn; Daniel L. ;   et al.
2008-10-30
Kinase Inhibitors Useful For The Treatment Of Myleoprolific Diseases And Other Proliferative Diseases
App 20080269267 - Flynn; Daniel L. ;   et al.
2008-10-30
Kinase Inhibitors Useful For The Treatment Of Myleoprolific Diseases And Other Proliferative Diseases
App 20080261965 - Flynn; Daniel L. ;   et al.
2008-10-23
Kinase Inhibitors Useful For The Treatment Of Myleoprolific Diseases And Other Proliferative Diseases
App 20080261961 - Flynn; Daniel L. ;   et al.
2008-10-23
Modulation Of Protein Functionalities
App 20080248548 - Flynn; Daniel L. ;   et al.
2008-10-09
Modulation Of Protein Functionalities
App 20080248487 - Flynn; Daniel L. ;   et al.
2008-10-09
Modulation of protein functionalities
App 20080220497 - Flynn; Daniel L. ;   et al.
2008-09-11
Anti-inflammatory medicaments
App 20080187978 - Flynn; Daniel L. ;   et al.
2008-08-07
Anti-inflammatory medicaments
App 20080132506 - Flynn; Daniel L. ;   et al.
2008-06-05
Kinase inhibitors useful for the treatment of proliferative diseases
App 20080114006 - Flynn; Daniel L. ;   et al.
2008-05-15
Enzyme Modulators And Treatments
App 20080113967 - Flynn; Daniel L. ;   et al.
2008-05-15
Kinase Inhibitors Useful For The Treatment Of Myleoproliferative Diseases And Other Proliferative Diseases
App 20080090856 - Flynn; Daniel L. ;   et al.
2008-04-17
Anti-inflammatory medicaments
App 20080064688 - Flynn; Daniel L. ;   et al.
2008-03-13
Anti-inflammatory medicaments
Grant 7,342,037 - Flynn , et al. March 11, 2
2008-03-11
Anti-inflammatory medicaments
App 20080045706 - Flynn; Daniel L. ;   et al.
2008-02-21
Anti-inflammatory medicaments
App 20080045531 - Flynn; Daniel L. ;   et al.
2008-02-21
Anti-cancer medicaments
Grant 7,279,576 - Flynn , et al. October 9, 2
2007-10-09
Anti-inflammatory medicaments
App 20070191336 - Flynn; Daniel L. ;   et al.
2007-08-16
Anti-inflammatory medicaments
Grant 7,202,257 - Flynn , et al. April 10, 2
2007-04-10
Substituted pyrazoles as p38 kinase inhibitors
App 20070078146 - Naraian; Ashok S. ;   et al.
2007-04-05
Enzyme modulators and treatments
App 20070078121 - Flynn; Daniel L. ;   et al.
2007-04-05
Anti-inflammatory medicaments
App 20070037808 - Flynn; Daniel L. ;   et al.
2007-02-15
Substituted pyrazoles as p38 kinase inhibitors
Grant 7,153,959 - Naraian , et al. December 26, 2
2006-12-26
Anti-inflammatory medicaments
Grant 7,144,911 - Flynn , et al. December 5, 2
2006-12-05
Substituted pyrazoles as p38 kinase inhibitors
Grant 7,071,198 - Naraian , et al. July 4, 2
2006-07-04
Anti-inflammatory medicaments
App 20050288286 - Flynn, Daniel L. ;   et al.
2005-12-29
Substituted pyrazoles as p38 kinase inhibitors
Grant 6,979,686 - Naraian , et al. December 27, 2
2005-12-27
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
Grant 6,951,848 - Harriman , et al. October 4, 2
2005-10-04
Method of using (H+/K+) ATPase inhibitors as antiviral agents
Grant 6,906,078 - Moorman , et al. June 14, 2
2005-06-14
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
App 20050075348 - Harriman, Geraldine C.B. ;   et al.
2005-04-07
Method of screening for target ligands
App 20050059038 - Adams, Steven P. ;   et al.
2005-03-17
2-amino-benzoxazinones for the treatment of viral infections
App 20050032793 - Abood, Norman ;   et al.
2005-02-10
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
App 20040220231 - Lee, Len F. ;   et al.
2004-11-04
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
Grant 6,794,396 - Lee , et al. September 21, 2
2004-09-21
Anti-inflammatory medicaments
App 20040180906 - Flynn, Daniel L. ;   et al.
2004-09-16
Substituted pyrazoles as p38 kinase inhibitors
App 20040176433 - Naraian, Ashok S. ;   et al.
2004-09-09
Anti-cancer medicaments
App 20040176395 - Flynn, Daniel L. ;   et al.
2004-09-09
Modulation of protein functionalities
App 20040171075 - Flynn, Daniel L. ;   et al.
2004-09-02
Electrophilic ketones for the treatment of herpesvirus infections
App 20040087491 - Flynn, Daniel L. ;   et al.
2004-05-06
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
App 20040038939 - Lee, Len F. ;   et al.
2004-02-26
2-Amino-benzoxazinones for the treatment of viral infections
Grant 6,683,077 - Abood , et al. January 27, 2
2004-01-27
Electrophilic ketones for the treatment of herpesvirus infections
Grant 6,673,788 - Flynn , et al. January 6, 2
2004-01-06
Electrophilic ketones for the treatment of herpesvirus infections
Grant 6,673,784 - Flynn , et al. January 6, 2
2004-01-06
Substituted pyrazoles as p38 kinase inhibitors
Grant 6,617,324 - Naraian , et al. September 9, 2
2003-09-09
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
Grant 6,605,624 - Lee , et al. August 12, 2
2003-08-12
Electrophilic ketones for the treatment of herpesvirus infections
App 20030119721 - Flynn, Daniel L. ;   et al.
2003-06-26
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
App 20030064991 - Harriman, Geraldine C.B. ;   et al.
2003-04-03
Substituted pyrazoles as p38 kinase inhibitors
Grant 6,525,059 - Anantanarayan , et al. February 25, 2
2003-02-25
Substituted pyrazoles as p38 kinase inhibitors
Grant 6,514,977 - Anantanarayan , et al. February 4, 2
2003-02-04
2-Amino-benzoxazinones for the treatment of viral infections
App 20030022895 - Abood, Norman ;   et al.
2003-01-30
Substituted pyrazoles as p38 kinase inhibitors
Grant 6,423,713 - Anantanarayan , et al. July 23, 2
2002-07-23
Method of using (H+/K+) ATPase inhibitors as antiviral agents
App 20010047038 - Moorman, Alan E. ;   et al.
2001-11-29
Method of using (H.sup.+ /K.sup.+)ATPase inhibitors as antiviral agents
Grant 5,945,425 - Moormann , et al. August 31, 1
1999-08-31
Meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
Grant 5,612,366 - Becker , et al. March 18, 1
1997-03-18
Imidazopyridines as serotonergic 5-HT.sub.3 antagonists
Grant 5,604,239 - Becker , et al. February 18, 1
1997-02-18
Benzimidazole compounds
Grant 5,521,193 - Flynn , et al. May 28, 1
1996-05-28
Azatetracycle compounds
Grant RE35,218 - Becker , et al. April 23, 1
1996-04-23
Process for the preparation of amidino phenyl pyrrolidine .beta.-alanine urea analogs
Grant 5,484,946 - Abood , et al. January 16, 1
1996-01-16
Imidazopyridines as serotonergic 5-HT.sub.3 antagonists
Grant 5,434,161 - Becker , et al. July 18, 1
1995-07-18
Indolones useful as serotonergic agents
Grant 5,399,562 - Becker , et al. March 21, 1
1995-03-21
3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents
Grant 5,376,670 - Connor , et al. December 27, 1
1994-12-27
Azanoradamantanes
Grant 5,354,757 - Flynn , et al. October 11, 1
1994-10-11
N-substituted lactams useful as cholecystokinin antagonists
Grant 5,314,886 - Becker , et al. May 24, 1
1994-05-24
Benzimidazole compounds
Grant 5,280,028 - Flynn , et al. January 18, 1
1994-01-18
Imidazopyridines as serotonergic 5-HT.sub.3 antagonists
Grant 5,260,303 - Becker , et al. November 9, 1
1993-11-09
Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof as pharmaceuticals
Grant 5,234,921 - Flynn , et al. August 10, 1
1993-08-10
Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxygenase inhibitors, pharmaceutical compositions and methods of use therefor
Grant 5,208,251 - Belliotti , et al. May 4, 1
1993-05-04
Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
Grant 5,155,110 - Connor , et al. October 13, 1
1992-10-13
3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents
Grant 5,155,122 - Connor , et al. October 13, 1
1992-10-13
Azatetracycle compounds
Grant 5,140,023 - Becker , et al. August 18, 1
1992-08-18
Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
Grant 5,137,893 - Becker , et al. August 11, 1
1992-08-11
N-azabicyclo [3.3.0]octane amides of aromatic acids
Grant 5,126,343 - Zabrowski , et al. June 30, 1
1992-06-30
Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues having cyclooxygenase and 5-lipoxygenase inhibition
Grant 5,112,868 - Cetenko , et al. May 12, 1
1992-05-12
N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
Grant 4,981,865 - Belliotti , et al. January 1, 1
1991-01-01
Triazole derivatives of fenamates as antiinflammatory agents
Grant 4,962,119 - Boschelli , et al. October 9, 1
1990-10-09
Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
Grant 4,943,587 - Cetenko , et al. July 24, 1
1990-07-24
N-substituted-2-hydroxy-.alpha.-oxo-benzeneacetamides and pharmaceutical compositions having activity as modulators of the arachidonic acid cascade
Grant 4,939,133 - Connor , et al. July 3, 1
1990-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed